Meet The Distinguished Faculty Leaders Who Shape The Academic Direction Of NMIMS Hyderabad
Experience: 9.8 Years
Teaching Interests: Anatomy, Physiology, Pharmacology, Toxicology, and Clinical Pharmacy
Research Interests: Pre-clinical research, clinical research and outcomes, pharmacovigilance, and clinical data management.
Research Profile:
Shruti S. Shiromwar is a Clinical Pharmacy researcher with nearly 10 years of academic and research experience, including significant international exposure in Malaysia and the Middle East. Her work spans pre-clinical and clinical pharmacology, with 21 peer-reviewed publications and many book chapters in reputed publishers.
Registered Pharmacist, Maharashtra State Pharmacy Council, Mumbai. No.82400
National Committee of Bio Ethics (NCEB) certification, Hosted by King Abdulaziz City for Science & Technology (KACST), Kingdom of Saudi Arabia, No: 1001463.
Registered member of the Saudi Heart Association, Registration ID: 10792245
Recent Publications:
Alqahtani, Y. S., Chidrawar, V. R., Shiromwar, S., Singh, S., Maheshwari, R., Chitme, H., Chilamakuru, N. B., Mohite, P., Aljameeli, A. M., & Khateeb, M. M. "A multi-modal approach to investigate Desmodium gangeticum's influence on stress-induced male infertility: In vivo, in vitro, and in silico assessments” (2024) Biomedicine & pharmacotherapy, 173, 116358. IF: 7.5, Elsevier
Divya, K Thanmaya, Chidrawar, Vijay R* Bhupalam, Pradeep Kumar; Shiromwar, Shruti, Aljameeli, Ahmed M, Vyshnavi, G.; Reddama, I. Sai, Boreddy, Vishali”. Assessment of knowledge and attitude of cervical cancer among the youths in the Rayalaseema region of Andhra Pradesh – India” Journal of Education and Health Promotion 13(1):73, February 2024. (ESCI, IF: 1.4)
Shruti Subhash Shiromwar, Vijay R. Chidrawar, Sudarshan Singh, Havagiray R. Chitme, Rahul Maheshwari & Shabnam Sultana "Multi-faceted Anti-obesity Effects of N-Methyl-D-Aspartate (NMDA) Receptor Modulators: Central-Peripheral Crosstalk.” Journal of Molecular Neuroscience 74, 13 (2024). https://doi.org/10.1007/s12031-023-02178-z. [IF:3 Springer Nature]
Amer Hayat Khan, Basavraj Sayabanna Nagoba, Shruti Subhash Shiromwar*. (2023) A critical review of risk factors influencing the prevalence of extensive drug-resistant tuberculosis in India. The International Journal of Mycobacteriology 12 (4), 372-379.
S S Shiromwar, A H Khan, V Chidrawar (2023) "A systemic review on extensive drug resistance tuberculosis from 2009-2020: Special emphasis on Treatment Outcomes (2023). Official Journal of Spanish Society of Chemotherapy” Rev Esp Quimioter. doi: 10.37201/req/029.2022. (Sociedad Espanola Quimioterapia, IF: 2.52)
